These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4679766)

  • 1. Psychiatric aspects of L-dopa therapy of Parkinson's disease.
    Pearlman CA; Sax DS; Feldman RD
    Psychiatry Med; 1972 Jan; 3(1):45-50. PubMed ID: 4679766
    [No Abstract]   [Full Text] [Related]  

  • 2. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
    Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A
    Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179
    [No Abstract]   [Full Text] [Related]  

  • 3. Mental disorders in Parkinson's disease after treatment with L-DOPA.
    Rondot P; de Recondo J; Coignet A; Ziegler M
    Adv Neurol; 1984; 40():259-69. PubMed ID: 6695602
    [No Abstract]   [Full Text] [Related]  

  • 4. Behavioral effects of l-dopa in man.
    Goodwin FK
    Semin Psychiatry; 1971 Nov; 3(4):477-92. PubMed ID: 5173049
    [No Abstract]   [Full Text] [Related]  

  • 5. Mental symptoms in Parkinson's disease during chronic treatment with levodopa.
    Sweet RD; McDowell FH; Feigenson JS; Loranger AW; Goodell H
    Neurology; 1976 Apr; 26(4):305-10. PubMed ID: 944387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Secondary effects of prolonged levodopa therapy in Parkinson's disease].
    Peiró Grasa A; Grau-Veciana JM
    Med Clin (Barc); 1985 Jun; 85(3):88-91. PubMed ID: 4021630
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mental disorders in patients with Parkinson's disease treated with L-dopa].
    Piccirilli M; Piccinin GL
    Clin Ter; 1981 Jun; 97(5):473-9. PubMed ID: 7273659
    [No Abstract]   [Full Text] [Related]  

  • 8. Mental symptoms in Parkinsonian patients treated with L-dopa.
    Jenkins RB; Groh RH
    Lancet; 1970 Jul; 2(7665):177-9. PubMed ID: 4193568
    [No Abstract]   [Full Text] [Related]  

  • 9. Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
    Duggal HS; Singh I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):583-4. PubMed ID: 18022304
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychiatric disturbances occurring during levodopa therapy of Parkinson's disease.
    Lloyd KG
    Prim Care; 1977 Sep; 4(3):561-75. PubMed ID: 264230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levodopa: long-term impact on Parkinson's disease.
    Br Med J (Clin Res Ed); 1981 Feb; 282(6262):417-8. PubMed ID: 6780051
    [No Abstract]   [Full Text] [Related]  

  • 12. [Psychiatric complications of L-dopa: physiopathology and treatment].
    Castro-García A
    Rev Neurol; 1997 Aug; 25 Suppl 2():S157-62. PubMed ID: 9280683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute psychoses and mood disorders in Parkinson disease. Role of antiparkinson therapy].
    Mouren P; Poinso Y; Oppenheim G; Mouren A; Nguyen Quang N
    Ann Med Psychol (Paris); 1983; 141(8):843-57. PubMed ID: 6666915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychiatric symptoms with initiation of carbidopa-levodopa treatment.
    Lin JT; Ziegler DK
    Neurology; 1976 Jul; 26(7):699-700. PubMed ID: 945518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropsychological findings in Parkinson's disease: a comparison between various tests during long-term levodopa therapy.
    Botez MI; Barbeau A
    Int J Neurol; 1975; 10(1-4):222-32. PubMed ID: 1181311
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute psychotic status after sudden interruption of treatment of Parkinsonism with levodopa].
    Ledić P; Sepcić J; Antoncić N
    Neurologija; 1977; 25(1-2):95-7. PubMed ID: 616879
    [No Abstract]   [Full Text] [Related]  

  • 17. [A case of mental change resulting from L-dopa treatment].
    Gulmann NC
    Ugeskr Laeger; 1976 Oct; 138(41):2497-8. PubMed ID: 973254
    [No Abstract]   [Full Text] [Related]  

  • 18. Parkinson's disease: drug-induced psychiatric states.
    Factor SA; Molho ES; Podskalny GD; Brown D
    Adv Neurol; 1995; 65():115-38. PubMed ID: 7872135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [L-dopa-induced psychoses and their treatment with L-tryptophan].
    Demling J
    Fortschr Med; 1986 Apr; 104(17):360-2. PubMed ID: 3710403
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Parkinson's disease with the combination drug L-carbidopa/L-dopa. Report on a 2 years study].
    Hayek J
    Schweiz Med Wochenschr; 1977 Apr; 107(14):474-9. PubMed ID: 847450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.